Skip to main content
Filing year 2023

DRUG STRATEGIES

Washington, District of Columbia·EIN 52-1837390·NTEE W20Z · Public & Societal Benefit·3
Total revenue
$1.9M
Total assets
$1.9M
Total expenses
$375k
Reported officers
8
Mission

DRUG STRATEGIES PROMOTES MORE EFFECTIVE APPROACHES TO THE NATION'S DRUG PROBLEMS AND SUPPORTS PRIVATE AND PUBLIC EFFORTS TO REDUCE THE DEMAND FOR DRUGS THROUGH PREVENTION, EDUCATION AND TREATMENT.

Executive compensation

Form 990 · Schedule J · 1 reported individual · Filing year 2023

Executive Dir/president
$118k
$130k

Teal figures restate each filed amount in 2026 dollars.

Estimated with Washington-Arlington-Alexandria, DC-VA-MD-WV metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 7 unpaid individuals.

Browse compensation in Public & Societal Benefit

Up 11%
from 2022

From $107k in 2022 to $118k in 2023.

$107k
2022
$118k
2023
In today's dollarsEst.
Up 7% in real terms$121k to $130k

Estimated with Washington-Arlington-Alexandria, DC-VA-MD-WV metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.